JOINN LABORATORIES(CHINA)CO.,LTD. Funds and ETFs Joinn Laboratories(China)Co.,Ltd.
Equities
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.45 CNY | -3.96% |
|
+6.47% | -26.40% |
ETFs positioned on Joinn Laboratories(China)Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 0 M€ | -12.22% | - | |
| 0.03% | 2 M€ | -.--% | ||
| 0.01% | 7 M€ | -.--% | - | |
| 0.00% | 0 M€ | +3.95% | - | |
| 0.00% | 0 M€ | +8.81% | - | |
| 0.00% | 0 M€ | +8.01% | - | |
| 0.00% | 0 M€ | +5.91% | - | |
| 0.00% | 0 M€ | +3.63% | - | |
| 0.00% | 0 M€ | +14.50% |
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.45
CNY
Average target price
18.66
CNY
Spread / Average Target
+6.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.40% | 1.67B | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- 603127 Stock
- Funds and ETFs Joinn Laboratories(China)Co.,Ltd.
